You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • THU0038 Bimekizumab dual inhibition of IL-17A and IL-17F provides evidence of IL-17F contribution to chronic inflammation in disease-relevant cells

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Cytokines and inflammatory mediators
THU0038 Bimekizumab dual inhibition of IL-17A and IL-17F provides evidence of IL-17F contribution to chronic inflammation in disease-relevant cells
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Maroof A, Okoye R, Smallie T, et al
THU0038 Bimekizumab dual inhibition of IL-17A and IL-17F provides evidence of IL-17F contribution to chronic inflammation in disease-relevant cells
Annals of the Rheumatic Diseases 2017;76:213.